https://www.selleckchem.com/products/gdc-0994.html
The m6A cluster 2 and high m6A score groups indicated a non-inflammatory phenotype, which may not be sensitive to immunotherapy but rather to targeted therapy. In this study, we first identified m6A clusters and m6A scores to elucidate immune phenotypes and to predict the prognosis and immunotherapy response in KIRC, which can guide urologists for making more precise clinical decisions.Background Gut microbiome is proved to affect the activity of immunotherapy in certain tumors. However, little is known if there is universal impact on
Like
Comment
Share
